Effect of antiresorptive therapy on aromatase inhibitor induced bone loss in postmenopausal women with early-stage breast cancer: A systematic review and meta-analysis of randomized controlled trials - Metabolism - Clinical and Experimental
Monitoring Antiresorptive Therapies: Assessing the Way We Evaluate Clinical Efficacy
Antiresorptive and anabolic agents in the prevention and reversal of bone fragility | Nature Reviews Rheumatology
Markers of bone turnover for monitoring antiresorptive treatment of osteoporosis
![PDF] Comparative effects of antiresorptive agents on bone mineral density and bone turnover in postmenopausal women | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/6c79716046fdb68c5859762f57fbbc8f6ed8f493/2-Table1-1.png "PDF] Comparative effects of antiresorptive agents on bone mineral density and bone turnover in postmenopausal women | Semantic Scholar")
PDF] Comparative effects of antiresorptive agents on bone mineral density and bone turnover in postmenopausal women | Semantic Scholar
Biochemical markers of bone remodeling
Effect of antiresorptive therapy on aromatase inhibitor induced bone loss in postmenopausal women with early-stage breast cancer: A systematic review and meta-analysis of randomized controlled trials - ScienceDirect
Evaluation of bone remodelling parameters after one year treatment with alendronate in postmenopausal women with osteoporosis | Bosnian Journal of Basic Medical Sciences
PDF) Effects of Previous Antiresorptive Therapy on the Bone Mineral Density Response to Two Years of Teriparatide Treatment in Postmenopausal Women with Osteoporosis | Bjorn Gudbjornsson and George Lyritis - Academia.edu
antiresorptive - Twitter Search / Twitter
BONE MARKERS IN MONITORING OF ANTIRESORPTIVE THERAPY IN POSTMENOPAUSAL OSTEOPOROSIS PATIENTS
Guidelines for the use of bone metabolic markers in the diagnosis and treatment of osteoporosis (2012 edition) | SpringerLink
PDF) Early Changes in Biochemical Markers of Bone Turnover Predict Bone Mineral Density Response to Antiresorptive Therapy in Korean Postmenopausal Women with Osteoporosis | Fernando Marín - Academia.edu
Antiresorptive and anabolic medications used in the perioperative period of patients with osteoporosis undergoing spine surgery:
Use of bone turnover markers in postmenopausal osteoporosis - The Lancet Diabetes & Endocrinology
Osteoporosis - The Lancet
Bone
Biochemical Makers of Bone Turnover - Use for Problem Assessment
Quantitative prediction of bone mineral density by using bone turnover markers in response to antiresorptive agents in postmenopausal osteoporosis: A model‐based meta‐analysis - Wu - 2021 - British Journal of Clinical Pharmacology -
JCM | Free Full-Text | Denosumab Discontinuation and the Rebound Phenomenon: A Narrative Review | HTML
PDF) BONE MARKERS IN MONITORING OF ANTIRESORPTIVE THERAPY IN POSTMENOPAUSAL OSTEOPOROSIS PATIENTS
Denosumab for treatment of osteoporosis in postmenopausal women
Biochemical markers for assessment of calcium economy and bone metabolism: application in clinical trials from pharmaceutical agents to nutritional products | Nutrition Research Reviews | Cambridge Core
Effect of Vitamin D Therapy on Bone Turnover Markers in Postmenopausal Women with Osteoporosis and Osteopenia - Endocrine Practice
On the effect of antiresorptive drugs on the bone remodeling of the mandible after dental implantation: a mathematical model | Scientific Reports
Changes (% ± SEM) in markers of bone resorption (NTX) and bone... | Download Scientific Diagram
